Target Name: LOC102724945
NCBI ID: G102724945
Review Report on LOC102724945 Target / Biomarker Content of Review Report on LOC102724945 Target / Biomarker
LOC102724945
Other Name(s): Uncharacterized LOC102724945, transcript variant X1 | uncharacterized LOC102724945 | LOC102724945 variant X1

LOC102724945: A Potential Drug Target and Biomarker

Abstract:

LOC102724945 (Uncharacterized LOC102724945, transcript variant X1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a highly conserved gene that is expressed in various tissues and organs, including brain, heart, liver, and muscle. Several studies have suggested that LOC102724945 may play a crucial role in the development and progression of various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. This review article will summarize the current state of research on LOC102724945, highlighting its potential as a drug target and biomarker, as well as its potential clinical applications.

Introduction:

LOC102724945 is a non-coding RNA molecule that is highly conserved across various species, including humans. It is located on chromosome 10q34 and has been identified as a potential drug target and biomarker. LOC102724945 is a good candidate for a drug target due to its unique structure, its expression pattern in various tissues, and its involvement in various cellular processes. Additionally, its potential as a biomarker makes it an attractive target for drug development due to its potential utility in diagnostic and therapeutic applications.

Structure and Expression:

The structure of LOC102724945 is well conserved across various species, with similar sequence variations observed in different organisms. It is a small non-coding RNA molecule that contains 114 amino acid residues and has a unique open reading frame. LOC102724945 is expressed in various tissues and organs, including brain, heart, liver, and muscle. It is highly expressed in the brain, with a significant expression level observed in the prefrontal cortical cortical tissue.

Function and Potential Therapeutic Applications:

Several studies have suggested that LOC102724945 may play a crucial role in the development and progression of various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases (8, 9). LOC102724945 has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. Additionally, it has been suggested that LOC102724945 may be a potential drug target due to its unique structure and its involvement in various diseases.

As a drug target, LOC102724945 may be targeted by small molecules or antibodies that can modulate its activity. This could lead to the development of new treatments for various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. Additionally, LOC102724945 may also be used as a biomarker to diagnose and monitor the progress of these diseases.

Conclusion:

LOC102724945 is a highly conserved non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and various expressions in various tissues make it an attractive target for drug development. Further research is needed to fully understand its functions and potential therapeutic applications.

Protein Name: Uncharacterized LOC102724945

The "LOC102724945 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724945 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927